Skip to main content
. Author manuscript; available in PMC: 2012 Mar 17.
Published in final edited form as: Int J Mol Med. 2010 Oct;26(4):447–455. doi: 10.3892/ijmm_00000484

Figure 4.

Figure 4

Proteasome-inhibitory effects of curcumin and its analogs on colon cancer cells. Human colon cancer cell lines HCT116 (A) and SW480 (B) were treated with the indicated concentrations of curcumin (CUR), curcumin monoacetate (AC-CUR) or curcumin diacetate (AC2-CUR) for 36 h, followed by the proteasomal chymotrypsin (CT)-like activity assay.